CMAJ • January 6, 2009; 180 (1). doi:10.1503/cmaj.1080124.
© 2009 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hubert, B.
Right arrow Articles by Gilca, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hubert, B., MD
Right arrow Articles by Gilca, R., MD
Related Collections
Right arrow Drugs: gastrointestinal system
Right arrow Drugs: infections
Right arrow Clostridium difficile

Letters

Use administrative databases with caution

Bruno Hubert, MD* and Rodica Gilca, MD{dagger}

*Institut de veille sanitaire, Nantes, France; {dagger}Institut national de santé publique du Québec, Québec City, Que.

There were 2 striking results in the article by Sandra Dial and colleagues: a sharp increase in the number of cases of community-acquired Clostridium difficile-associated diarrhea in 2003 and 2004 in Quebec and a low rate of antibiotic exposure in the weeks preceding the infection.1 The authors used the provincial hospital discharge summary (MED-ECHO) database to identify the cases on the basis of the first hospital admission for which C. difficile infection was listed as the primary diagnosis. This was considered to be a clinically relevant case definition of community-acquired C. difficile infection.

However, MED-ECHO coding rules state that the primary diagnosis is "the most important condition encountered by the patient during his hospitalization. In most cases, it is closely related to the reason for admission. In a patient with multiple conditions, the physician should assign the primary diagnosis to the condition requiring the greatest use of medical resources during the hospital stay."2 Consequently, in patients with severe C. difficile- associated diarrhea acquired during a hospital stay and requiring intensive care or a prolonged hospital stay, this condition is more likely to be recorded as the primary diagnosis than is the reason for admission.

This potential for misclassification has 2 major implications for the study by Dial and colleagues.1 First, one cannot exclude the possibility that the increase in the number of so called community-acquired C. difficile-associated diarrhea in 2003 and 2004 reflects an increase in the number of nosocomial cases, given that the spread of the NAP1 strain in Quebec was associated with more severe disease.3,4 Second, as the index date of the potentially misclassified cases was defined as the admission date, antibiotics given during hospital stay were not included in the study. This would lead to an underestimation of the antibiotic exposure in these cases. The use of administrative databases requires a good understanding of the coding rules, which are not always suitable for epidemiologic analyses.

Footnotes

Competing interests: None declared.


REFERENCES

  1. Dial S, Kezouh A, Dascal A, et al. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 2008;179:767-72.[Abstract/Free Full Text]
  2. Ministère de la santé et des services sociaux. Cadre normative du système Med-Echo. Québec City (QC): The Ministry; 2007.Available: http://msssa4.msss.gouv.qc.ca/fr/document/publication.nsf/4b1768b3f849519c852568fd0061480d/581d207c3ed564a7852574bf005283de?OpenDocument (accessed 2008 Dec. 3).
  3. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9.[Abstract/Free Full Text]
  4. Hubert B, Loo VG, Bourgault AM, et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007;44:238–44.[CrossRef][Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hubert, B.
Right arrow Articles by Gilca, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hubert, B., MD
Right arrow Articles by Gilca, R., MD
Related Collections
Right arrow Drugs: gastrointestinal system
Right arrow Drugs: infections
Right arrow Clostridium difficile